6.48 USD
0 (0%)
6.48 USD
0 (0%)
ChartMill assigns a Buy % Consensus number of 80% to FRLN. The Buy consensus is the weighted average rating of the current analysts ratings.
Analysts have set a mean price target forecast of 8.42. This target is 29.86% above the current price.
FRLN was analyzed by 8 analysts. The buy percentage consensus is at 80. So analysts seem to be have mildly positive about FRLN.
In the previous month the buy percentage consensus was at a similar level.
FRLN was analyzed by 8 analysts. More opinions would make the average more meaningful.
Price Target & Forecast
| Date | Firm | Action | Rating |
|---|---|---|---|
| 2023-11-28 | HC Wainwright & Co. | Downgrade | Buy -> Neutral |
| 2023-10-18 | Wedbush | Downgrade | Outperform -> Neutral |
| 2023-08-17 | HC Wainwright & Co. | Reiterate | Buy -> Buy |
| 2023-08-16 | Stifel | Maintains | Hold -> Hold |
| 2023-08-01 | HC Wainwright & Co. | Reiterate | Buy -> Buy |
| 2023-06-01 | Stifel | Reiterate | Hold -> Hold |
| 2023-05-31 | HC Wainwright & Co. | Reiterate | Buy |
| 2023-04-05 | Stifel | Downgrade | Buy -> Hold |
| 2023-04-05 | HC Wainwright & Co. | Maintains | Buy |
| 2022-08-22 | HC Wainwright & Co. | Maintains | Buy |
| 2022-08-11 | BTIG | Maintains | Buy |
| 2022-02-01 | Morgan Stanley | Downgrade | Overweight -> Equal-Weight |
| 2022-01-07 | Redburn Partners | Upgrade | Neutral -> Buy |
| 2021-11-29 | BTIG | Initiate | Buy |
| 2021-08-18 | HC Wainwright & Co. | Maintains | Buy |
| 2021-08-17 | JP Morgan | Downgrade | Overweight -> Neutral |
| 2021-05-19 | HC Wainwright & Co. | Initiate | Buy |
| 2021-05-06 | Guggenheim | Initiate | Buy |
| 2021-04-06 | Morgan Stanley | Maintains | Overweight |
| 2021-03-23 | Mizuho | Initiate | Buy |
| 2021-03-02 | Stifel | Initiate | Buy |
FREELINE THERAPEUTICS HOLDIN / FRLN FAQ
Can you provide the average price target for FREELINE THERAPEUTICS HOLDIN stock?
8 analysts have analysed FRLN and the average price target is 8.41 USD. This implies a price increase of 29.86% is expected in the next year compared to the current price of 6.48.
Can you provide the consensus rating for FREELINE THERAPEUTICS HOLDIN stock?
The consensus rating for FREELINE THERAPEUTICS HOLDIN (FRLN) is 80 / 100 . This indicates that analysts generally have a positive outlook on the stock.
How many analysts cover FREELINE THERAPEUTICS HOLDIN (FRLN) stock?
The number of analysts covering FREELINE THERAPEUTICS HOLDIN (FRLN) is 8.